Antimicrobial Susceptibility Testing Market

Agreements, Partnerships, and Collaborations are the Key Growth Strategies Adopted by Leading Players in the Esoteric Testing Market Between 2014 and 2017

The global esoteric testing market is projected to reach USD 35.24 Billion by 2023 from 20.38 Billion in 2018, at a CAGR of 11.6%. Factors such as the increasing global burden of target diseases, rising demand for early and accurate disease diagnosis, advancements in clinical diagnostic techniques, growing public-private investments as well as research funding & grants to develop innovative laboratory testing procedures, and rising government initiatives to improve the quality and affordability of esoteric diagnostic testing procedures are driving the growth of the esoteric market. However, the dearth of skilled laboratory technicians and inadequate reimbursement will limit the growth of this market.

Service developments and agreements, partnerships, and collaborations are the key growth strategies adopted by leading market players between 2014 and 2017. Some of the companies that adopted this strategy include LabCorp (US), OPKO Health (US), Miraca Holdings (US), Myriad Genetics (US), Quest Diagnostics (US), Sonic Healthcare (UK), American Medical Laboratories (US), Foundation Medicines (US), Mayo Medical Laboratories (US), and Fulgent Genetics (US)

The esoteric testing market is highly competitive with the presence of several big and small players. Prominent players offering services for esoteric testing include LabCorp (US), Quest Diagnostics (US), OPKO Health (US), Miraca Holdings (US), ARUP Laboratories (US), Myriad Genetics (US), Genomic Health (US), American Medical Laboratories (US), Foundation Medicines (US), Mayo Medical Laboratories (US), Primary Healthcare (Australia), Healthscope (Australia), Sonic Healthcare (UK), Fulgent Genetics (US), Spectra Laboratories (US), Nordic Lifesciences (US), InVitae (US), Unilabs (Switzerland), and SYNLAB (Germany).

Laboratory Corporation of America Holdings (US) is the leading player in the esoteric testing market. The company has a strong network of 39 laboratories and 1,700 patient service centers, and a network of branches and STAT laboratories across the US, Canada, and the UK. Through a combination of organic growth and disciplined acquisitions, LabCorp has continually expanded and diversified its business. Over the past three years, the company adopted acquisitions as its key growth strategy. For instance, in 2017, LabCorp (US) acquired Bode Technology (UK) and Pathology Associates Medical Laboratories (PAML) (US). In 2016, the company acquired Pathology (US) to expand its service offerings in the esoteric testing market. Inorganic growth strategies such as acquisitions and collaborations helped the company to sustain its leading position and enter high-growth markets.

Quest Diagnostics Incorporated (US) is one of the prominent players in the esoteric testing market. The company offers diagnostic testing services ranging from routine biological tests to complex and specialized molecular and gene-based testing. It has a laboratory network in the US, Puerto Rico, Mexico, India, and Ireland. It has primarily adopted acquisitions as its key strategy to increase its market share in the global esoteric testing market. In the last three years, the company has acquired the outreach laboratory service business of Hartford HealthCare (US), The Hospital of Central Connecticut (US), Clinical Laboratory Partners (US), Cape Cod Healthcare (CCHC, US), MemorialCare Health Systemís laboratory outreach service business, Steward Health Care Systemís outreach laboratory services business, and Solstas Lab Partners (US).

Related Reports:

Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Neurology, Genetic Testing), Lab Type (Independent Labs, Hospital Laboratories), Technology (Mass Spectrometry, CLIA, ELISA, PCR) - Global Forecast to 2023

Contact:
Mr. Rohan
MarketsandMarketsô INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Report Code
MD 5931
Published ON
Jan, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Antimicrobial Susceptibility Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved